Bioventus (BVS) director Pat Beyer receives 25,146 RSUs and converts 32,282 into Class A shares
Rhea-AI Filing Summary
Bioventus Inc. director Pat Beyer reported equity compensation activity and an option-like vesting event. On June 3, 2026, Beyer received a grant of 25,146 restricted stock units, each representing a contingent right to one share of Class A common stock. These RSUs will vest on the earlier of the day immediately preceding the issuer's first annual meeting of stockholders following the grant date or the first anniversary of the grant, subject to continued board service.
On June 2, 2026, previously granted RSUs vested and were exercised into 32,282 shares of Class A common stock, eliminating that RSU balance. Following these transactions, Beyer holds 108,718 shares of Class A common stock directly and 25,146 RSUs that remain outstanding.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Restricted Stock Units | 25,146 | $0.00 | $0.00 |
| Exercise | Restricted Stock Units | 32,282 | $0.00 | $0.00 |
| Exercise | Class A Common Stock | 32,282 | $0.00 | $0.00 |
Footnotes (3)
- F1. Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A common stock.
- F2. The RSUs vested on June 2, 2026.
- F3. The RSUs shall vest and become exercisable on the earlier of (i) the day immediately preceding the date of the Issuer's first Annual Meeting of Stockholders following the date of grant and (ii) the first anniversary of the date of grant, subject to the Reporting Person continuing in service on the Issuer's Board of Directors through the applicable vesting date.
Key Figures
Key Terms
Restricted Stock Units financial
Class A Common Stock financial
Grant, award, or other acquisition financial
Exercise or conversion of derivative security financial
vest financial
AI-generated analysis. How Rhea-AI works. Not financial advice.